Heart Disease News and Research

Latest Heart Disease News and Research

SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths

study reveals that SGLT2 inhibitors consistently lower the risk of major adverse cardiovascular events by 9% across various patient groups, especially impacting cardiovascular death reduction, highlighting their broad therapeutic potential beyond diabetes management.

9 Apr 2024

Boosting heart health with rewards and fun: How incentives and games encourage exercise

Study found that combining financial incentives with gamification significantly boosts physical activity in adults at risk for cardiovascular events, suggesting a potent strategy for risk reduction.

9 Apr 2024

Labels reveal the truth: "Ultra-processed" and "high in sugar" deter shoppers

Study highlights that labeling foods as "ultra-processed" can significantly influence US adults' perceptions of health risks and discourage purchase intentions, especially when labels also indicate high sugar content.

8 Apr 2024

Step steady: Consistent walking improves brain function in older adults

Study highlights that stabilizing daily step variability, rather than increasing total step counts, improves cognitive flexibility in older adults following a 10-week physical activity intervention.

8 Apr 2024

Beta-blockers show no benefit for heart attack patients with normal heart function

The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.

8 Apr 2024

Adherence to the EAT-Lancet diet reduces the risk of heart failure

Adherence to the EAT-Lancet diet, rich in plant-based foods, is associated with a reduced risk of heart failure, potentially mediated by specific plasma proteins, in a large population-based cohort study.

8 Apr 2024

TAVR demonstrates lower risk and improved outcomes compared to SAVR in low-risk patients

Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated with substantial decreased rates of death or stroke at one year in low-risk patients, compared with surgical aortic valve replacement (SAVR), according to findings presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Chronic low-level inflammation may be a contributor to both depression and heart disease

Coronary artery disease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers at Vanderbilt University Medical Center and Massachusetts General Hospital have found.

8 Apr 2024

Nerve ablation's varied outcomes in high blood pressure treatment

A new system that uses dehydrated alcohol to deactivate certain nerves surrounding the kidneys' arteries in order to control high blood pressure met its primary endpoint—lowering blood pressure at three months as measured with a 24-hour ambulatory systolic blood pressure monitor—in a pivotal phase 3 trial presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Preventive PCI reduces cardiac event risks in patients with high-risk plaque

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous coronary intervention (PCI), a procedure to open blocked arteries, compared with those who took medications alone but did not undergo PCI, according to research presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

IVUS guidance improves angioplasty success rates in patients with peripheral artery disease

One-year success rates from angioplasty procedures to open clogged arteries in the legs were significantly higher among patients whose procedures were guided by intravascular ultrasound (IVUS) alongside angiography compared with those whose procedures were guided by angiography alone, in a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Ninerafaxstat shows good tolerability and safety in nonobstructive HCM patients

The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with evidence of improvements in symptoms and exercise capacity among people with nonobstructive hypertrophic cardiomyopathy (HCM), according to results of a 12-week phase 2 trial presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

DEPOSITION trial evaluates the use of topical tranexamic acid during heart surgery

Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically rather than intravenously did not meet its primary endpoint of reducing seizures and was stopped early due to an increased risk of bleeding events, according to research presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes did not meet its primary endpoint, but a preplanned subgroup analysis found a statistically significant effect of treatment in patients who were not taking SGLT2 inhibitors or GLP-1 RAs, which are antidiabetic medications that also have benefits for the heart.

8 Apr 2024

Preventive ventricular tachycardia ablation cuts down ICD shocks and hospitalizations

The first randomized trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients at high risk of ventricular arrhythmias (VAs) reduces the risk of appropriate implantable cardioverter-defibrillator (ICD) therapy and unplanned hospitalization in patients with no previously recorded VAs.

8 Apr 2024

ACE inhibitors show no benefit in reducing chemotherapy-induced heart damage

Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracycline chemotherapy did not show any difference in troponin T levels, a biomarker associated with heart damage, at one month after their last chemotherapy dose compared with those who did not take an ACE inhibitor, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Poor oral health linked to negative long-term systemic health outcomes

Those who report having poor oral health are as likely to have negative long-term systemic health outcomes as those previously diagnosed with periodontal disease, or gum disease, according to a new Tufts University School of Dental Medicine study published in The Journal of the American Dental Association.

8 Apr 2024

New technology uses a smartphone to analyze heart movement, detect heart failure

The new technology, which was created at the University of Turku and developed by the company CardioSignal, uses a smartphone to analyze heart movement and detect heart failure.

8 Apr 2024

New cryoablation technique eliminates ventricular tachycardia in 94% of patients

A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science is presented at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).

8 Apr 2024

SMART trial shows comparable outcomes of two common TAVR devices in small aortic annulus patients

People with a small aortic annulus, a part of the heart's anatomy where the left ventricle meets the aorta, who underwent transcatheter aortic valve replacement (TAVR) with a supra-annular self-expanding valve saw similar clinical outcomes and superior valve performance at one year compared with those who underwent TAVR with a balloon-expandable valve, according to research presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Previous
1
...
67
68
69
70
71
72
73
...
2870
Next

Heart Disease News and Research

Latest Heart Disease News and Research

SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths

Boosting heart health with rewards and fun: How incentives and games encourage exercise

Labels reveal the truth: "Ultra-processed" and "high in sugar" deter shoppers

Step steady: Consistent walking improves brain function in older adults

Beta-blockers show no benefit for heart attack patients with normal heart function

Adherence to the EAT-Lancet diet reduces the risk of heart failure

TAVR demonstrates lower risk and improved outcomes compared to SAVR in low-risk patients

Chronic low-level inflammation may be a contributor to both depression and heart disease

Nerve ablation's varied outcomes in high blood pressure treatment

Preventive PCI reduces cardiac event risks in patients with high-risk plaque

IVUS guidance improves angioplasty success rates in patients with peripheral artery disease

Ninerafaxstat shows good tolerability and safety in nonobstructive HCM patients

DEPOSITION trial evaluates the use of topical tranexamic acid during heart surgery

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

Preventive ventricular tachycardia ablation cuts down ICD shocks and hospitalizations

ACE inhibitors show no benefit in reducing chemotherapy-induced heart damage

Poor oral health linked to negative long-term systemic health outcomes

New technology uses a smartphone to analyze heart movement, detect heart failure

New cryoablation technique eliminates ventricular tachycardia in 94% of patients

SMART trial shows comparable outcomes of two common TAVR devices in small aortic annulus patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Heart Disease News and Research

Latest Heart Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in